Hsbc Holdings PLC Purchases 6,253 Shares of Addus HomeCare Corporation $ADUS

Hsbc Holdings PLC raised its position in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 79.6% during the 1st quarter, Holdings Channel.com reports. The firm owned 14,113 shares of the company’s stock after purchasing an additional 6,253 shares during the period. Hsbc Holdings PLC’s holdings in Addus HomeCare were worth $1,333,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Global Retirement Partners LLC increased its stake in shares of Addus HomeCare by 395.7% in the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after purchasing an additional 186 shares in the last quarter. Larson Financial Group LLC lifted its stake in shares of Addus HomeCare by 133.3% during the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after buying an additional 136 shares in the last quarter. Acumen Wealth Advisors LLC purchased a new position in shares of Addus HomeCare during the 4th quarter valued at $29,000. Private Trust Co. NA boosted its holdings in Addus HomeCare by 65.5% in the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after buying an additional 112 shares during the period. Finally, Arax Advisory Partners boosted its holdings in Addus HomeCare by 95.8% in the 4th quarter. Arax Advisory Partners now owns 280 shares of the company’s stock worth $30,000 after buying an additional 137 shares during the period. 95.35% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

ADUS has been the topic of a number of recent analyst reports. Barclays raised their price target on Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a report on Wednesday, July 8th. Citigroup reaffirmed a “market outperform” rating on shares of Addus HomeCare in a research note on Friday. Citizens Jmp reiterated a “market outperform” rating and set a $142.00 target price on shares of Addus HomeCare in a research report on Monday, May 18th. Finally, Weiss Ratings raised Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Addus HomeCare presently has a consensus rating of “Moderate Buy” and a consensus price target of $131.50.

Addus HomeCare Stock Performance

ADUS opened at $115.65 on Tuesday. The stock has a market capitalization of $2.16 billion, a price-to-earnings ratio of 21.38, a PEG ratio of 1.57 and a beta of 0.88. The company has a fifty day moving average of $99.71 and a 200 day moving average of $101.23. Addus HomeCare Corporation has a fifty-two week low of $87.95 and a fifty-two week high of $124.43. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.83 and a current ratio of 1.83.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, May 4th. The company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.52 by $0.10. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The business had revenue of $363.50 million for the quarter, compared to analysts’ expectations of $366.41 million. During the same quarter in the previous year, the company earned $1.42 EPS. The business’s quarterly revenue was up 7.7% compared to the same quarter last year. As a group, sell-side analysts forecast that Addus HomeCare Corporation will post 6.24 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Heather Brianne Dixon sold 288 shares of Addus HomeCare stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the sale, the insider directly owned 44,371 shares of the company’s stock, valued at approximately $4,160,668.67. The trade was a 0.64% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 788 shares of company stock valued at $73,506 over the last quarter. Insiders own 4.10% of the company’s stock.

Addus HomeCare Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.